Xcout IntelSign inSubscribe

Treace Medical Concepts, Inc. competitors & alternatives

TMCIMedical DevicesPonte Vedra, United States

The 12 closest competitors and alternatives to Treace Medical Concepts, Inc. among medical devices companies — ranked by similarity to what Treace Medical Concepts, Inc. actually does, not by market-cap band.

$274.4MMarket cap
432Employees
12Competitors listed

Subscribe to see Treace Medical Concepts, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Treace Medical Concepts, Inc. at a glance

Treace Medical Concepts, Inc. is a medical devices company headquartered in Ponte Vedra, United States. It is publicly listed (TMCI) with a market capitalisation of $274.4M. Xcout tracks 19 named people at Treace Medical Concepts, Inc., including Mark L. Hair (Chief Financial Officer).

Treace Medical Concepts, Inc. leadership

  • Mark L. HairChief Financial Officer
  • Sean F. ScanlanChief Innovation & Marketing Officer
  • Scot ElderChief Legal & Compliance Officer and Corporate Secretary
  • Daniel E. OwensChief Human Resources Officer
  • Taylor EricksonChief Information & Cybersecurity Officer
  • Terry W. LubbenChief Operations & Supply Chain Officer

13 more named people on record for Treace Medical Concepts, Inc., with roles, board committees and tenure — see the full roster →

Treace Medical Concepts, Inc. funding rounds on record

Every round on record:

DateRoundAmountInvestors
Series A$2.1M—

Some filings are not shown as funding rounds.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 Treace Medical Concepts, Inc. competitors

Ranked by semantic similarity — how close each company is to Treace Medical Concepts, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Axogen, Inc.AXGN · Medical DevicesAlachua, United States
67% matchPublicAI 30/100Green 3/100

Similar medical devices company

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.

Market cap$1.9B
Employees622
GCPSpring
Axogen, Inc. competitors & alternatives →
Aurora Spine CorporationASG · Medical - DevicesToronto, Canada
67% matchPublic

Medical - Devices

Established in 2013 and headquartered in Toronto, Canada, Aurora Spine Corporation, through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spinal fusion systems and devices within the Canadian market. The company offers a comprehensive portfolio of products designed to address various spinal conditions, particularly degenerative disc diseases. This includes interspinous process lumbar fusion devices such as the ZIP series (ZIP, ZIP ULTRA, ZIP LP, and ZIP-51). Aurora Spine also provides Ti-Coated polyether ether ketone (PEEK) interbody cages, which are crucial for maintaining space and stability between vertebrae while facilitating bone fusion. Its offerings extend to sterile-packed titanium plasma spray coated spinal fusion implants that promote bone growth. Key interbody products comprise EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar region, and Discovery for cervical applications. The company also manufactures SOLO, an anterior lumbar interbody fusion (ALIF) 3D-printed stand-alone device featuring an integrated plate and spacer system for anatomical preservation and spinal support. For sacroiliac joint issues, Aurora Spine provides SiLo, a posterior fusion device. Furthermore, the DEXA-C cervical interbody system, a porous 3D-printed intervertebral body fusion device with customizable lattice density options, is available to match patient bone quality.

Market cap$321.1M
Employees13
Aurora Spine Corporation competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Treace Medical Concepts, Inc. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Treace Medical Concepts, Inc.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →